Market higher; Teva report beats estimates on Copaxone
February 17, 2009 at 09:57 AM EST
TEL AVIV (MarketWatch) -- Israel stocks were lower on Tuesday, with a drop in Israel Chemicals and other key blue chips offset by strength in Teva Pharmaceutical, after its stronger-then-expected earnings report, and in selected technology issues.
